Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED BALANCE SHEETS

v3.24.3
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2024
Mar. 31, 2023
Current Assets:    
Cash $ 2,085 $ 12,839
Accounts receivable, net of allowances of $3,287 at March 31, 2024 and $4,813 at March 31, 2023 6,552 7,102
Inventories 20,642 37,328
Prepaid expenses and other current assets 5,449 7,447
Total current assets 34,728 64,716
Property, plant, equipment and rental assets, net 25,854 24,275
Finance lease right-of-use assets 4,391 4,529
Operating lease right-of-use assets 12,279 8,808
Non-current portion of inventories 3,917 3,112
Other assets 3,037 2,591
Total assets 84,206 108,031
Current Liabilities:    
Accounts payable and accrued expenses 18,212 30,290
Accrued salaries and wages 1,220 1,223
Accrued warranty reserve 1,437 1,576
Deferred revenue 11,183 23,372
Finance lease liability, current 964 773
Operating lease liability, current 4,041 2,492
Factory protection plan liability 7,259 10,844
Term note payable, current   50,983
Exit new money notes, net of discount, current 28,911  
Total current liabilities 73,227 121,553
Deferred revenue, non-current 675 817
Finance lease liability, non-current 2,300 2,903
Operating lease liability, non-current 8,527 6,588
Other non-current liabilities 264 265
Total liabilities 84,993 132,126
Commitments and contingencies (Note 14)
Temporary equity:    
Redeemable noncontrolling interests 13,859  
Stockholders' deficiency:    
Preferred stock, $.001 par value; 1,000,000 shares authorized; none issued
Additional paid-in capital 955,145 955,228
Accumulated deficit (969,810) (977,202)
Treasury stock, at cost; 0 shares at March 31, 2024 and 117,014 shares at March 31, 2023   (2,139)
Total stockholders' deficiency (14,646) (24,095)
Total liabilities, temporary equity and stockholders' deficiency 84,206 108,031
Common Stock    
Stockholders' deficiency:    
Common stock 18 $ 18
Non-Voting Common Stock    
Stockholders' deficiency:    
Common stock $ 1